About the LUCE-1 Trial LUCE-1 is a Phase 1/2 multicenter, open-label, dose escalation study investigating safety, tolerability and preliminary efficacy of 3 dose levels of dual AAV8.MYO7A (AAVB-081) ...
Streaming is an actively evolving technology, writes Wheatstone's Rick Bidlack, and the queen of streaming, metadata, will ...
Six poster presentations highlight CARVYKTI® efficacy, safety, and real-world outcomes across CARTITUDE trials and analyses, ...
Morning Overview on MSN
Inside the shadowy AI lab built for one purpose only: trigger goosebumps
In a nondescript building on the edge of a research campus, a small team of scientists is training machines to do something ...
" data-display-label="0" data-show-count="1" data-bookmark-label="Save" data-bookmarked-label="Saved" data-loggedin="0" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback